Tuberculosis in Siberia: 2. Diagnosis, chemoprophylaxis and treatment

Tubercle and Lung Disease

Volumn 77, Issue 4, 1996, Pages 297-301

  Drobniewski, F ^a   Tayler, E ^b   Ignatenko, N ^c   Paul, J ^d   Connolly, M ^e   Nye, P ^f   Lyagoshina, T ^c   Besse, C ^c  

^a Dulwich Community Hospital   (United Kingdom)

^b Department of Microbiology   (United Kingdom)

^c Medical Emergency Relief International   (United Kingdom)

^d JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^e Kingston and Richmond Hlth Auth   (United Kingdom)

^f UNIVERSITY COLLEGE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; ISONIAZID; STEROID; TUBERCULOSTATIC AGENT;

ARTICLE; BLOOD AUTOTRANSFUSION; CHEMOPROPHYLAXIS; CLINICAL FEATURE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LUNG LOBECTOMY; LUNG RESECTION; ORAL DRUG ADMINISTRATION; RADIODIAGNOSIS; TUBERCULOSIS; ULTRAVIOLET IRRADIATION; USSR;

EID: 0029774073     PISSN: 09628479     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0962-8479(96)90092-1     Document Type: Article

References (17)

1. Drobniewski F, Tayler E, Ignatenko N et al. Tuberculosis in Siberia: 1. an epideraiological and microbiological assessment. Tubercle Lung Dis 1996; 77: 199-206.
2. Raviglione M C, Rieder H L, Styblo K, Khomenko A G, Esteves K, Kochi A. Tuberculosis trends in Eastern Europe and the former USSR. Tubercle Lung Dis 1994; 75: 400-416.
3. Central Research Institute of Tuberculosis, Russian Academy of Medical Science. Tuberculosis in Russia. 1994.
4. Ministry of Health, Russian Federation. Prikaz (Edict) No 527. 1988.
5. World Health Organisation. Guidelines for tuberculosis treatment in adults and children in national tuberculosis programmes. 1991. WHO/TB,91,161. WHO, Geneva, Switzerland.
6. World Health Organisation. Treatment of tuberculosis. Guidelines for National Programmes. 1993. WHO Geneva Switzerland.
7. Committee on Treatment, International Union Against Tuberculosis and Lung Disease. Antituberculosis regimens of chemotherapy. Bull Int Union Tuberc Lung Dis 1988; 63: 60-64.
8. Zhukova M P, Punga V V, Kovaleva S I, Rybka L N, Nefedov B A, Nagornyi A M. Tuberculosis morbidity in the USSR: population and its basic trends. Problemy Tuberculosa 1991; N11: 22-24.
9. Israel H L. Chemoprophylaxis for tuberculosis. Respir Med 1993; 87: 81-83.
10. Moulding T S, Redeker A G, Kanel G C. Twenty isoniazid associated deaths in one state. Am Rev Respir Dis 1989; 140: 700-705.
11. Snider D E, Tabas G J. Isoniazid associated hepatitis deaths: a review of available information. Am Rev Respir Dis 1992; 145: 494-497.
12. Clancy L, Rieder H L, Enarson D A, Spinaci S. Tuberculosis elimination in the countries of Europe and other industrialised countries. Eur Respir J 1991; 4: 1288-1295.
13. Mahmoudi A, Iseman M D. Pitfalls in the care of patients with tuberculosis. Common errors and their association with the acquisition of drug resistance. JAMA 1993; 270: 65-68.
14. American Thoracic Society. Treatment of tuberculosis and tuberculosis infection in adults and children. Am J Respir Crit Care Med 1994; 149: 1359-1374.
15. Fox W. Whither short course chemotherapy? Br J Dis Chest 1981; 75: 331-357.
16. Drobniewski F A, Uttley A C. Tuberculosis treatment programmes. Lancet. 1994; 344: 610.
17. Weil D E C. Drug supply: meeting a global need. In: Tuberculosis - Back to the future. Porter J D H, McAdam K P W J, eds. Chichester, England: John Wiley and Sons. 1994: 123-136.